Metoprolol Succinate ER in pharma franchise in Tamil Nadu

Metoprolol Succinate ER in PCD pharma franchise in Kohima

Metoprolol Succinate ER in top pharma company in Kolkata

Metoprolol Succinate ER in pcd pharma supplier in Jaipur

Metoprolol Succinate ER in phama franchise company in india
Metoprolol Succinate ER in phama distributor in Raipur

Home/Products /metoprolol-succinate-prolonged-50-mg-tablet

About the Product

Description


Metoperil XL 50 Tablet is a once-daily extended-release formulation containing Metoprolol Succinate 50 mg, a beta-1 selective adrenergic blocker. This medication is primarily used in the treatment of hypertension (high blood pressure), angina (chest pain), and chronic heart failure, and plays a vital role in post-myocardial infarction care. It effectively helps reduce the risk of future cardiovascular events by controlling heart rate, reducing blood pressure, and improving overall heart function.

As an extended-release formulation, Metoperil XL 50 ensures a steady release of the drug over 24 hours, providing round-the-clock therapeutic coverage. By selectively blocking beta-1 receptors in the heart, it reduces the effects of stress hormones such as adrenaline, helping to slow down the heart rate and lower the workload on the heart. This results in better control of blood pressure and prevention of heart-related complications.

Metoperil XL 50 is commonly prescribed as part of long-term cardiovascular therapy. It not only helps control elevated blood pressure but also supports patients with stable angina by reducing the frequency and severity of chest pain. In patients with chronic heart failure, it improves exercise tolerance and reduces the need for hospitalization. The 50mg strength is often used for moderate hypertension or as a step-up dose in patients who require enhanced beta-blocker support.

This medicine is well-tolerated when taken regularly and under medical supervision. Lifestyle modifications such as salt reduction, weight management, regular exercise, and stress control should be practiced alongside therapy for optimal results.

It is important for patients not to discontinue the medicine abruptly, as sudden withdrawal may lead to chest pain, high blood pressure spikes, or even heart attacks in those with pre-existing cardiac conditions.

Possible side effects include fatigue, dizziness, bradycardia (slow heart rate), hypotension, and cold hands or feet.

Indicated for the management of hypertension, angina, and chronic heart failure.

Do not discontinue the medicine abruptly; consult your doctor before making any changes to dosage or therapy.

Store in a cool, dry place below 30°C. Protect from light and moisture.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Metoprolol Succinate 50 mg ER Tablets in the PCD pharma franchise market?

Metoprolol Succinate 50 mg ER (Extended Release) Tablets have strong demand in the cardiology and chronic care segment, making them a high-value prescription product for pharma distributors, wholesalers, and franchise partners. It is widely prescribed for hypertension, chronic stable angina, heart failure, arrhythmias, and cardiovascular risk reduction, ensuring consistent long-term prescription demand.

Why should medical distributors include Metoprolol Succinate 50 mg ER Tablets in their product range?

Medical distributors and agencies benefit from the rising prevalence of hypertension and cardiovascular disorders. Helps effectively control high blood pressure Supports management of chronic stable angina Used in heart failure treatment under physician supervision Helps manage certain cardiac rhythm disorders (arrhythmias) Extended-release formulation provides 24-hour therapeutic coverage with once-daily dosing Widely prescribed by cardiologists and general physicians Strong demand in hospital, clinic, and retail pharmacy segments This makes it a high-demand chronic cardiovascular care product with excellent repeat prescription potential.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Metoprolol Succinate 50 mg ER Tablets with monopoly rights, promotional support, quality manufacturing standards, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and franchise partners benefit from steady cardiology prescription demand, long-term patient adherence, strong physician confidence, and stable year-round turnover in the cardiovascular segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and pharma franchise partners can contact Cafoli LifeCare Pvt Ltd to discuss monopoly territory rights, pricing structure, marketing support, and complete cardiology and antihypertensive product portfolio access to build a strong presence in the cardiovascular healthcare market.